Institute of Immune Pharmacology
-
Prof. Dr. med. Heinfried H.
Radeke
|
(Dr.-Schleussner-Foundation
of Immune Pharmacology)
|
|
| |
> |
Profile
The Dr.-Hans-Schleussner-Foundation
of Immune Pharmacology offers
sophisticated expertise in in
vitro test systems and models
of chronic inflammation as well
as expertise in immune therapy
of e.g. nephritis, rheumatoid
arthritis, vasculitis, dermatitis,
transplantation and tumour immunology.
With this background the group
is focused on developing targeted
delivery techniques for disease
modifying recombinant proteins,
oligonucleotides and viral shuttle
vectors.
|
> |
Expertise
- Detailed assessment and
monitoring of immunological
parameters in human patients,
especially in Nephritis, Kidney
Transplantation, Rheumatoid
Arthritis, Inflammatory Bowel
Disease, Autoimmune Endocrinopathy
and Lymphatic Leukemia after
Stem Cell Transplantation
- Single cell immune assays
to determine dendritic cell
maturation parameters and
antigen-specific T lymphocyte
responses
- Primary human and murine
tissue cells serving as in
vitro models of chronic inflammation
and autoimmune disease, such
as nephritis, rheumatoid arthritis,
vasculitis, dermatitis, transplantation,
and tumour immunology
- Static and dynamic test
systems to measure adhesion,
chemotaxis and transmigration
of immune cells in vitro and
in vivo to identify new targets
and develop molecular biological
strategies for an anti-inflammatory
therapy
- Examination of signal transduction
pathways and Gene and Protein
expression patterns in inflammation
with the goal to identify
novel therapeutic targets
- Screening and evaluation
of novel Gene and Protein
delivery systems, e.g. combination
of retroviral expression vectors
for TFO or siRNA with immunoliposome
targeting towards endothelial
cells in static and dynamic
flow chamber systems
- Profound molecular biological
knowledge: i.e. vector-development
, gene silencing und gene
regulation (triple helix forming
ODNs, RNA interference as
well as the construction of
designer transcriptions-factors
|
|
> |
Resources
and Abilities
- 96 well „high throughput“
single cell analysis microscope-video-computer
system (Zeiss/ Hamamatsu/
Improvision) for automated
chemotaxis assay analysis
and fluorochrome-based signal
transduction studies
- Eukaryotic and Prokaryotic
cloning and protein expression
system
- High-volume Sartorius Cross-Flow
Protein Purification System
(DFG loan)
- MACS Magnetic Bead cell
enrichment system (Miltenyl)
- Automated ELISA Spot Assay
Video Analysis System: single
and dual color ELISPOT to
measure cytokine secreting
cell frequency
- Circular flow chamber and
in cooperation with W.H. Boehncke
intravital video microscopy
- 96 well luminometer: „High
Throughput“ Gene Reporter
Assay with Prof. Dr. J.M.
Pfeilschifter
|
|
| |
| >
|
Publications
- Radeke HH, von Wenckstern
H, Stoidtner K, Sauer B, and
Kleuser B. Overlapping signaling
pathways of sphingosine 1-phosphate
and TGF-ß in murine
Langerhans cells. Journal
of Immunology, 2004, in revision
- Kautz K, Schwarz M and Radeke
HH. Interference with MCP-1
gene expression by vector
generated triple helix-forming
RNA oligonucleotides. Human
Gene Therapy, 2004, in revision
- Xu D, Falke D and Junliano
RL. P53-Dependent Cell-Killing
by selective repression of
thymidine kinase and reduced
prodrug activation. Molecular
Pharmacology, 2003, 64:289-297
- Falke D, Fisher M, Ye D
and Juliano RL. Design of
artificial transcription factors
to selectively regulate the
pro-apoptotic Bax gene. Nucleic
Acids Research, 2003, 31:3
e10
- Radeke HH; Janssen-Graalfs
I; Sowa EN; Chouchakova N;
Skokowa J; Löscher F;
Schmidt RE; Heeringa P; Gessner
JE. Opposite regulation of
type II and III receptors
for immunoglobulin G in mouse
glomerular mesangial cells
and in the induction of anti-glomerular
basement membrane (GBM) nephritis.
Journal of Biological Chemistry,
277:27535-27544, 2002
- Radeke HH; Tschernig T;
Karulin A; Schumm G; Emancipator
SN; Resch K; Tary-Lehmann
M. CD4+ T cells recognizing
specific antigen deposited
in glomeruli cause glomerulonephritis-like
kidney injury. Clinical Immunology,
104(2):161-173, 2002
- Marchand P; Resch K; Radeke
HH. Selective Inhibition of
monocyte chemoattractant protein-1
(MCP-1) gene transcription
in embryonic kidney cells
by specific triple helix-forming
oligonucleotides. Journal
of Immunology, 2000, 164:2070-2076
|
|
| |
> |
Staff:
Head of the Foundation:
- Prof. Dr. med. Heinfried
H. Radeke
Co-Worker:
- Dr. rer. nat. Dietmar Falke,
Group Leader (molecular biology,
delivery systems)
- Dr. med. Frank Behrens (human
tissue and immune cell isolation,
ELISPOT)
- Dr. rer.nat. Judith Calderwood
(static and dynamic adhesion
and chemotactic assays)
|
> |
ZAFES-coordinator:
|
> |
ZAFES-deputy:
|
|
|
|
|